Endocrine News

Introducing the New President: Gary D. Hammer, MD, PhD

The Endocrine Society is pleased to welcome its president for 2020–2021, Gary D. Hammer, MD, PhD, who took office at the Society’s virtual business meeting on April 6. As director of the Endocrine Oncology Program at the University of Michigan Rogel Cancer Center in Ann Arbor, his work on adrenal homeostasis focuses on progenitor cell...

Individuals Taking Class of Steroid Medications at High Risk for COVID-19

JCEM Editors examine pandemic’s impact on endocrine patients in editorial Individuals taking a class of steroid hormones called glucocorticoids for conditions such as asthma, allergies and arthritis on a routine basis may be unable to mount a normal stress response and are at high risk if they are infected with the virus causing COVID-19, according...

Poor Fitness May Impede Long-Term Success in Weight Loss Program

People who are very out of shape when they begin a behavioral weight loss program lose less weight in the long term than those who are more fit, a new study suggests. The results were presented during a virtual news conference hosted by the Endocrine Society. “This research could help us improve the design of...

Artificial Intelligence Improves X-ray Identification of Patients with Broken Bones

Artificial intelligence that can “read” electronic radiology reports and flag patients with broken bones who are at risk of osteoporosis outperformed the traditional manual method of health care professionals reading X-ray reports, a new study finds. The results were presented during a virtual news conference hosted by the Endocrine Society. The new search tool, called...

Endocrine Society Updates Osteoporosis Clinical Practice Guideline

New recommendations include romosozumab therapy for high risk patients The Endocrine Society today announced an update to its osteoporosis Clinical Practice Guideline to include recommendations for romosozumab, a new medication that was approved last year to treat postmenopausal women at high risk of fracture. The U.S. Food and Drug Administration approved romosozumab in April 2019,...

Endocrine Society Applauds Failure of South Dakota Bill to Restrict Medical Care for Transgender Teenagers

The Endocrine Society is pleased a South Dakota bill that would have barred healthcare providers from treating transgender teenagers using evidence-based clinical practice guidelines is not moving forward this session. Several states are considering legislation that would carry penalties of jail time and fines for healthcare providers who treat transgender teenagers using evidence-based practices. These...

Endocrine Society Elects Wysham as 2021-2022 President

Wysham, Carol - approved August 2015_jpg

Five endocrinologists to join Board of Directors Endocrine Society members have elected Carol H. Wysham, MD, to serve as the organization’s President for the 2021-2022 term. Wysham is an endocrinologist at Rockwood/MultiCare Health Systems in Spokane, Wash., and Clinical Professor of Medicine at the University of Washington. She will serve as President-Elect for a year...

Mind Your Business: How to Get the Financial Resources and the Administrative Support for Your Innovation

It helps to be able to “talk the talk” and make the business case as well as the clinical case for new expenses. Healthcare is one of the sectors where technical innovation is taking place at a break-neck pace. A practice that is slow to adapt will be slow to catch up to an everchanging...

Endocrine News

Endocrine news on twitter